BioSpace News Archive

Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced it will release its third quarter 2021 financial results for the period ended March 26, 2021 after market close on Monday, May 3, 2021. On that day, management will hold a conference call and webcas

-Data presentation to be released online at 10:00 AM ET on Friday, April 23, 2021 -Live Q&A session with presenter to be held on Saturday, April 24, 2021 at 3:00 PM ET

CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that Rob Davidson, CURE’s Chief Executive Officer, and Nancy Duitch, CEO of subsidiary Sera Labs and Chief Strategic Officer of CURE, will be presenting virtually at a cannabis investing conference, the 2021 Sequire Cannabis Conference, on Tuesday, April 20, at 2 p.m. EDT/11 a.m. PDT.

- New data support role of Percepta Genomic Atlas in genomic profiling for lung cancer patients – - Study suggests Envisia classifier can be successfully enabled on nCounter Analysis System -

Shreis Scalene Therapeutics LLC (SSTx), a MD-USA-based medical device company has fast-tracked the marketing and distribution of the CE-marked (EU-Class 1) Scalene Hypercharge Corona Canon (SHYCOCAN®), that is currently market-enabled under “US FDA’s ‘Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019

Jackson Healthcare®, a family of highly specialized healthcare staffing, search and technology companies, today announced that it has purchased the last manufacturing facility in the United States that is authorized to produce Amoxicillin and Amoxicillin Clavulanate,

Advanced Human Imaging Limited (ASX: AHI) (“AHI” or the “Company”) is pleased to announce that it has entered into a binding licensing and investment agreement with Canadian-based Triage Technologies Inc. (Triage), a worldwide leader in dermatological mobile health

Stella is proud to announce the nationwide expansion of access to the trauma treatment technique called the Stellate Ganglion Block (SGB), a breakthrough treatment for PTSD recently featured in Forbes.

Greenwald’s experience in public relations and marketing will play a key role in the growth of AngioSoma

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2021 first quarter on Monday, May 10, 2021 before the open of the U.S. financial markets.